LanceBio Ventures
Geographic focus: US/EU/Israel · Assets under management: 150000000 · Years in business: 14 · Average hold period: 5 years · Employees: 4
LanceBio Ventures is a Delaware-based VC firm investing in the development of advanced therapies across US/EU/Israel. With two successful funds the team was deeply involved with, LanceBio Ventures is launching its 150M private fund with the goal to transform lives of patients with highest unmet medical needs. Our previous track record includes 50+ invested public and private US/EU companies, 8 NASDAQ IPOs, 10 M&As. We leverage a unique network of VC-peers, the visibility in the biotech VC community, and deepest scientific expertise and strategic support to our portfolio companies to consistently generate steady ~20% returns for our LPs over 10+ years.
More sponsors on LPShares
- JDL Ventures
- JLN Properties LLC
- Kainan Investments LLC
- Kings Capital
- Kingsbarn Realty Capital
- Lana Management, LLC
- Le Creme Partners
- Leone Real Estate Partners
- LPShares
- Luna Corpa
- M&A Development
- Mailbox Money
- 272 HOLDINGS
- Big Tasty Hospitality
- Centra Capital Partners
- DWCRE
- Four Rivers Capital
- Infogito Holdings LLC
- Malabar Hill Capital
- NITYA REAL ESTATE LCC
- Prosperity CRE
- Shelter Asset Management
- TG Partners
- Valoris Capital